title: The spectrum of mutations in UBE3A causing Angelman syndrome.
abstract: Angelman syndrome (AS) is characterized by mental retardation, absence of speech, seizures and motor dysfunction. AS is caused by maternal deletions for chromosome 15q11-q13, paternal uniparental disomy (UPD), imprinting defects or loss-of-function mutations in the UBE3A locus which encodes E6-AP ubiquitin-protein ligase. The UBE3A gene is imprinted with paternal silencing in human brain and similar silencing of the Ube3a locus in Purkinje cells and hippocampal neurons in the mouse. We have sequenced the major coding exons for UBE3A in 56 index patients with a clinical diagnosis of AS and a normal DNA methylation pattern. The analysis identified disease-causing mutations in 17 of 56 patients (30%) including 13 truncating mutations, two missense mutations, one single amino acid deletion and one stop codon mutation predicting an elongated protein. Mutations were identified in six of eight families (75%) with more than one affected case, and in 11 of 47 isolated cases (23%); no mutation was found in one family with two siblings, one with a typical and one with an atypical phenotype. Mutations were de novo in nine of the 11 isolated cases. An amino acid polymorphism of threonine substituted for alanine at codon 178 was identified, and a 3 bp length polymorphism was found in the intron upstream of exon 8. In all informative cases, phenotypic expression was consistent with imprinting with a normal phenotype when a mutation was on the paternal chromosome and an AS phenotype when a mutation was on the maternal chromosome. Laboratory diagnosis and genetic counseling for AS are complex, and mutation analysis is valuable in clinically typical AS patients with a normal methylation analysis.
authors.affiliation: Department of Molecular and Human Genetics, Baylor College of Medicine and Howard Hughes Medical Institute, Houston, TX, USA.
authors.forename: P
authors.initials: P
authors.lastname: Fang
authors.forename: E
authors.initials: E
authors.lastname: Lev-Lehman
authors.forename: T F
authors.initials: TF
authors.lastname: Tsai
authors.forename: T
authors.initials: T
authors.lastname: Matsuura
authors.forename: C S
authors.initials: CS
authors.lastname: Benton
authors.forename: J S
authors.initials: JS
authors.lastname: Sutcliffe
authors.forename: S L
authors.initials: SL
authors.lastname: Christian
authors.forename: T
authors.initials: T
authors.lastname: Kubota
authors.forename: D J
authors.initials: DJ
authors.lastname: Halley
authors.forename: H
authors.initials: H
authors.lastname: Meijers-Heijboer
authors.forename: S
authors.initials: S
authors.lastname: Langlois
authors.forename: J M
authors.initials: JM
authors.lastname: Graham
authors.forename: J
authors.initials: J
authors.lastname: Beuten
authors.forename: P J
authors.initials: PJ
authors.lastname: Willems
authors.forename: D H
authors.initials: DH
authors.lastname: Ledbetter
authors.forename: A L
authors.initials: AL
authors.lastname: Beaudet
mesh_terms: D017204:Angelman Syndrome / Q000201:enzymology* / Q000235:genetics*; D000818:Animals; D001483:Base Sequence; D004252:DNA Mutational Analysis; D017931:DNA Primers / Q000235:genetics; D005091:Exons; D005260:Female; D005817:Genetic Counseling; D014644:Genetic Variation; D018392:Genomic Imprinting; D006801:Humans; D008025:Ligases / Q000235:genetics*; D008297:Male; D051379:Mice; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D044767:Ubiquitin-Protein Ligases
chemical_list: D017931:DNA Primers; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases; D008025:Ligases